Day One Biopharmaceuticals (NASDAQ: DAWN) ripped higher on Friday morning after Servier signed a definitive agreement to acquire the California-based firm for about $2.5 billion in cash. Servier’s deal rewrites…
-
-
Micron Technology shares fell on Friday as weakness in South Korean memory names weighed on sentiment and US investors awaited February jobs data. The moves come as US stocks remained…
-
A lot of people are wondering if they should buy Bitcoin. A lot of people are also wondering if it is a viable option to the methods of payment we…
-
So without further ado, let’s walk through some of the most common red flags below. Be Careful About Reputation You’ve heard about a great new currency you like the…
-
Building wealth is a sprint; it rewards speed and concentration. Protecting wealth is a marathon; it rewards patience and design. The strategies that brought you to where you are…
-
What is President Javier Milei, really: a savior, or a bankruptcy trustee? An anarchist, a populist, or a classical-liberal reformer? Is he dismantling the casta — the entrenched political establishment…
-
Wars test nations. They test military readiness, alliance cohesion, and political resolve. But they also test something less visible and just as important: fiscal strength. Just days before the United…
-
The industrial age reshaped production and reorganized work, elevating coordination to a central concern for firms. In response, early approaches to management emphasized structure and control, with performance judged primarily…
-
Every time conflict erupts in the Middle East and oil prices jump, the same anxiety follows: will central banks respond with tighter money? It’s an understandable fear. Households dislike inflation,…
-
Daily headlines formulate new variations on the theme: artificial intelligence is too powerful to be left unregulated. Lawmakers, guardedly seconded by big tech CEOs, warn of catastrophe. Agencies draft frameworks.…